Journals / Türkiye Çocuk Hastalıkları Dergisi / 2020 / Cilt: 14 - Sayı: EK SAYI 1

SARS-CoV-2 in Terms of Medical Microbiology Laboratory

Tıbbi Mikrobiyoloji Laboratuvarı Açısından SARS-CoV-2

Pages
18–25
Publication Date
2022-11-06
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Since the World Health Organization (WHO) defines SARS-CoV-2-sourced COVID-19 as a pandemic, and because of the increasing number of cases and deaths worldwide, structure of the novel virus and viral diagnosis methods gained importance respectively for vaccine studies and for controlling the outbreak caused by the virus.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Coronaviruses (CoV), which are in the Coronaviridae family, cause different severity of gastrointestinal, respiratory and systemic diseases in wild and domestic animals, and can lead to different clinical manifestations, ranging from colds to pneumonia, depending on immunity.
📊
Key Findings & Data:To date, seven types of coronavirus have been identified as infectious agents in humans; of these, HCoV 229E, HCoV NL63, HCoV HKU1 and HCoV OC43 typically cause cold symptoms in immunocompetent individuals, while SARS-CoV (Severe Acute Respiratory Syndrome Coronavirus) and MERS-CoV (Middle East Respiratory Syndrome Coronavirus) is zoonotic and cause severe respiratory diseases and deaths.
💡
Conclusion & Impact:Since the World Health Organization (WHO) defines SARS-CoV-2-sourced COVID-19 as a pandemic, and because of the increasing number of cases and deaths worldwide, structure of the novel virus and viral diagnosis methods gained importance respectively for vaccine studies and for controlling the outbreak caused by the virus.
🔬Design:Research Article
📍Scope:2019 Verileri
⚙️Variables:Domain Parameters

Abstract

Coronaviruses (CoV), which are in the Coronaviridae family, cause different severity of gastrointestinal, respiratory and systemic diseases in wild and domestic animals, and can lead to different clinical manifestations, ranging from colds to pneumonia, depending on immunity. To date, seven types of coronavirus have been identified as infectious agents in humans; of these, HCoV 229E, HCoV NL63, HCoV HKU1 and HCoV OC43 typically cause cold symptoms in immunocompetent individuals, while SARS-CoV (Severe Acute Respiratory Syndrome Coronavirus) and MERS-CoV (Middle East Respiratory Syndrome Coronavirus) is zoonotic and cause severe respiratory diseases and deaths. SARSCoV-2, the causative agent of COVID-19, is the seventh coronavirus identified as an infection agent in humans, which started in December 2019 in Wuhan, Hubei Province of China and was identified as a pandemic in a short time. Since the World Health Organization (WHO) defines SARS-CoV-2-sourced COVID-19 as a pandemic, and because of the increasing number of cases and deaths worldwide, structure of the novel virus and viral diagnosis methods gained importance respectively for vaccine studies and for controlling the outbreak caused by the virus.

Özet

Coronaviridae ailesinde yer alan koronaviruslar (CoV), vahşi ve evcil hayvanlarda farklı şiddette gastrointestinal, respiratuvarve sistemik hastalıklara neden olurken, insanlarda bağışıklık durumuna göre soğuk algınlığından pnömoniye kadar farklıklinik tablolara yol açabilir. Günümüze dek insanlarda enfeksiyon etkeni olarak yedi koronavirus türü tanımlanmıştır;bunlardan HCoV 229E, HCoV NL63, HCoV HKU1 ve HCoV OC43, tipik olarak immünokompetan bireylerde soğukalgınlığı semptomlarına neden olurken, SARS-CoV (Ciddi Akut Solunum Sendromu Koronavirus), MERS-CoV (OrtaDoğu Solunum Sendromu Koronavirus) zoonotiktir ve ciddi solunum yolu hastalıklarına ve ölümlere neden olur. Çin’inHubei Eyaleti, Wuhan kentinde Aralık 2019’da başlayan ve kısa sürede pandemi olarak tanımlanan COVID -19’un etkeniSARS-CoV-2 insanlarda enfeksiyon etkeni olarak tanımlanan yedinci koronavirustur. Dünya Sağlık Örgütü(DSÖ)’nünSARS-CoV-2 kaynaklı COVID-19’u pandemi olarak tanımlaması ve dünya üzerinde her geçen gün vaka ve ölümsayılarının artmasından dolayı, aşı çalışmaları için virusun yapısı ve salgını kontrol etmede en önemli basamak olan viraltanı yöntemlerinin kullanılması daha da önem kazanmıştır.

🔖

Cite This Article

AYDOĞAN, S., DİNÇ, B. (2022). SARS-CoV-2 in Terms of Medical Microbiology Laboratory. Türkiye Çocuk Hastalıkları Dergisi, Cilt: 14 - Sayı: EK SAYI 1, 18–25. https://ajindex.com/articles/627676

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Coronaviridae Study Group of the International Committee on Taxonomy of Viruses. The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2.Nature Microbiology 2020;5:536–44. 2.
  2. Cui J, Li F, Daszak P. Origin and evolution of pathogenic coronaviruses. Nat Rev Genet 2018; 17: 181–92
  3. Su S, Wong G, Shi W, Liu J, Lai A C K, Zhou J et al. Epidemiology, genetic recombination, and Pathogenesis of coronaviruses.Trends Microbiol 2016; 24:490–502
  4. Ksiazek TG, Erdman D, Goldsmith CS, Zaki SR, Peret T, Emery S, et al. A novel coronavirus associated with severe acute respiratory syndrome. N Engl J Med 2003; 348: 1953–66
  5. Peiris JS, Lai ST, Poon LL, Guan Y, Yam LY, Lim W et al. Coronavirus as a possible cause of severe acute respiratory syndrome.Lancet 2003; 361:1319–25
  6. Zaki AM, van Boheemen S, Bestebroer TM, Osterhaus AD, Fouchier RA. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med 2012; 367:1814–20
  7. Assiri A, Al-Tawfiq JA, Al-Rabeeah AA, Al-Rabiah FA, Al-Hajjar S, Al-Barrak A, et al. Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study. Lancet Infect Dis 2013;13:752–61
  8. Park SE. Epidemiology, virology, and clinical features of severe acute respiratory syndrome - coronavirus-2 (SARS-CoV-2; Coronavirus Disease-19). Clin Exp Pediatr 2020;63:119-24
  9. Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, et al. A Pneumonia Outbreak Associated with a New Coronavirus of Probable Bat Origin. Nature 2020; 579:270-3
  10. Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med 2020;382:727−33
  11. Wu A, Peng Y, Huang B, Ding X, Wang X, Niu P, et al. Commentary Genome Composition and Divergence of the Novel Coronavirus (2019-nCoV) Originating in China. Cell Host Microbe 2020;27:325- 8
  12. Ren LL, Wang YM, Wu ZQ, Xiang ZC, Guo L, Xu T, et al. Identification of a novel coronavirus causing severe pneumonia in human: a descriptive study. Chin Med J (Engl) 2020;133:1015-24
  13. Chan JF, Yuan S, Kok KH, To KK, Chu H, Yang J, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating personto-person transmission: a study of a family cluster. Lancet 2020;395:514-23
  14. Song Z, Xu Y, Bao